Advertisement
Canada markets open in 2 hours

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7323
    -0.0000 (-0.00%)
     

  • CRUDE OIL

    84.17
    +0.60 (+0.72%)
     

  • Bitcoin CAD

    87,605.25
    +425.42 (+0.49%)
     

  • CMC Crypto 200

    1,385.10
    -11.44 (-0.82%)
     

  • GOLD FUTURES

    2,358.90
    +16.40 (+0.70%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,757.25
    +189.75 (+1.08%)
     

  • VOLATILITY

    15.55
    +0.18 (+1.17%)
     

  • FTSE

    8,119.63
    +40.77 (+0.50%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     

Today's Research Reports on Fennec Pharmaceuticals, Baylin Technologies, CRH Medical and Cotinga Pharmaceuticals

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / October 30, 2018 / MarketEdge Report strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com/ and get exclusive access to our numerous research reports and market updates.

MER Initiates Coverage on:

Fennec Pharmaceuticals Inc.
https://marketedgereport.com/report/FRX.TO/

Baylin Technologies Inc.
https://marketedgereport.com/report/BYL.TO/

CRH Medical Corporation
https://marketedgereport.com/report/CRH.TO/

Cotinga Pharmaceuticals Inc.
https://marketedgereport.com/report/COT.V/

ADVERTISEMENT

Fennec Pharmaceuticals’ stock moved 11.63% lower Monday, to close the day at $8.36. The stock recorded a trading volume of 1,955 shares, which was above its three months average volume of 1,867 shares. In the last year, Fennec Pharmaceuticals' shares have traded in a range of 8.36 - 18.86. The share price has fallen 0% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $10.29 is lower than its 200-day moving average of $13.03. Shares of Fennec Pharmaceuticals have fallen approximately 33.07 percent year-to-date.

Access MER's Fennec Pharmaceuticals Inc. Research Report at:
https://marketedgereport.com/report/FRX.TO/

On Monday, shares of Baylin Technologies recorded a trading volume of 8,250 shares, which was below the three months average volume of 32,566 shares. The stock ended the day 1.64% lower at $3.59. The share price has fallen 16.32% from its 52week high with a52 week trading range of 1.94 - 4.29. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.80 is greater than its 200-day moving average of $3.50. Shares of Baylin Technologies have gained approximately 4.36 percent year-to-date.

Access MER's Baylin Technologies Inc. Research Report at:
https://marketedgereport.com/report/BYL.TO/

CRH Medical’s stock moved 3.26% lower Monday, to close the day at $3.86. The stock recorded a trading volume of 170,764 shares, which was below its three months average volume of 223,350 shares. In the last year, CRH Medical's shares have traded in a range of 1.86 - 5.91. The share price has gained 107.53% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.85 is greater than its 200-day moving average of $4.52. Shares of the company are trading at a Price to Earnings ratio of 35.09. Shares of CRH Medical have gained approximately 16.62 percent year-to-date.

Access MER's CRH Medical Corporation Research Report at:
https://marketedgereport.com/report/CRH.TO/

On Monday, shares of Cotinga Pharmaceuticals recorded a trading volume of 95,000 shares, which was above the three months average volume of 57,333 shares. The stock ended the day 7.14% lower at $0.065. The share price has fallen 95.67% from its 52week high with a52 week trading range of 0.05 - 1.50. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.134 is lower than its 200-day moving average of $0.429. Shares of Cotinga Pharmaceuticals have fallen approximately 93.64 percent year-to-date.

Access MER's Cotinga Pharmaceuticals Inc. Research Report at:
https://marketedgereport.com/report/COT.V/

Our Actionable Research on Fennec Pharmaceuticals Inc. (TSX:FRX.TO), Baylin Technologies Inc. (TSX:BYL.TO), CRH Medical Corporation (TSX:CRH.TO) and Cotinga Pharmaceuticals Inc. (TSXV:COT.V) can be downloaded free of charge at MarketEdge Report.

MarketEdge Report

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

MarketEdge Report has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

MarketEdge Report, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: MarketEdge Report